Maximise health outcomes

Patient behavioural risk: PSP engagement

Even if you make significant investment in around-the-pill support, a lack of patient trust in either the value of the programme or the medication can impact on programme effectiveness and the value to healthcare providers, ultimately resulting in poorer health outcomes.

Solutions

Utilising evidence-based models, we design and deliver effective behaviourally intelligent solutions, either to augment and improve existing PSPs or provide you with proven standalone interventions.

PSP Design

Custom Advisory Services

Research and expertise from our recognised experts help identify behavioural barriers in PSP design. Our methodologies draw on evidence-based behavioural frameworks to reduce nonadherence risk and help you maximise patient engagement.

Insight and Evaluation

MARS™ / BMQ™ / TARA™
Applied at key points, our tools help you understand how effective a PSP is and identify areas for improvement.

Engagement Strategy

PERSIGNIA™ (powering intelligent personalised engagement)
Our validated algorithmic capability rapidly triages a patient’s risk of nonadherence, surfacing personalised content to support the best health outcomes for your patients.

Activating Change

TARA-Activate™ 
Evidence-based message development turns behavioural insight into actionable communications that make a positive difference.

 

Case Study

Enhancing engagement and adherence with a Patient Support Programme (PSP) for breast cancer management

Read Case Study

Would you like to find out more about how we can help you improve clinical trial design, commercial success or patient engagement?